glp-1 semaglutide vs ozempic vs. Wegovy vs. Mounjaro: What's the Difference? Ozempic vs Semaglutide : A

In addition, since the first evidence of a beneficial effect of GLP-1RAs in BAD treatment was not available until 2019, we notice that the prescriptions of GLP-1RAs up until this year were made for other indications than BAD in contrast to bile acid sequestrants

This is a big reason why these medications are designed for long-term use

Add GIP receptor activation, as Tirzepatide does, and you layer in improved insulin sensitivity, enhanced fat metabolism, and what appears to be reduced GI side effects compared to GLP-1-only approaches

References: Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J